|
DENND4C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.101600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.830000E-02 |
| Normal-vs-Stage2 |
4.701600E-01 |
| Normal-vs-Stage3 |
2.801900E-02 |
| Normal-vs-Stage4 |
3.604500E-03 |
| Stage1-vs-Stage2 |
8.304400E-01 |
| Stage1-vs-Stage3 |
2.154900E-04 |
| Stage1-vs-Stage4 |
1.50751999999921E-05 |
| Stage2-vs-Stage3 |
4.096000E-02 |
| Stage2-vs-Stage4 |
1.131960E-02 |
| Stage3-vs-Stage4 |
4.175200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.341600E-01 |
| Normal-vs-AfricanAmerican |
2.154400E-01 |
| Normal-vs-Asian |
6.059400E-01 |
| Caucasian-vs-AfricanAmerican |
1.944790E-01 |
| Caucasian-vs-Asian |
7.268600E-01 |
| AfricanAmerican-vs-Asian |
3.574600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.761000E-01 |
| Normal-vs-Female |
2.539200E-01 |
| Male-vs-Female |
1.641840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.677400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.352200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.971400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.820800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.651600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.871400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.340000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.529600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.356200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.983400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.692130E-02 |
| Normal-vs-Grade 2 |
2.434400E-02 |
| Normal-vs-Grade 3 |
1.595960E-01 |
| Normal-vs-Grade 4 |
2.51320000033139E-07 |
| Grade 1-vs-Grade 2 |
9.113700E-02 |
| Grade 1-vs-Grade 3 |
3.641300E-04 |
| Grade 1-vs-Grade 4 |
8.01430000141323E-08 |
| Grade 2-vs-Grade 3 |
1.183730E-04 |
| Grade 2-vs-Grade 4 |
4.18887147191072E-12 |
| Grade 3-vs-Grade 4 |
3.97389999999831E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.570740E-04 |
| Normal-vs-ccB subtype |
2.744500E-03 |
| ccA subtype-vs-ccB subtype |
6.89415191601483E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.443400E-01 |
| Normal-vs-N1 |
6.900900E-03 |
| N0-vs-N1 |
5.016200E-02 |
|
|
